Clindamycin Palmitate Hydrochloride
- Product NDC
- 62135-926
- 11-digit product format
- 621350926
- Labeler code
- 62135
- Product ID
- 62135-926_3e9fcb79-a752-3d33-e063-6394a90a48ea
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Clindamycin Palmitate Hydrochloride
- Dosage form
- GRANULE, FOR SOLUTION
- Route
- ORAL
- Labeler
- Chartwell RX, LLC
- Application
- ANDA206958
- Marketing category
- ANDA
- Marketing start
- 2017-05-05
- Substance
- CLINDAMYCIN PALMITATE HYDROCHLORIDE
- Active strength
- 75 mg/5mL
- Pharmacologic classes
- Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Clindamycin Palmitate Hydrochloride
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| CLINDAMYCIN PALMITATE HYDROCHLORIDE | 75 mg/5mL |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | VN9A8JM7M7 |
| Rxcui | 562266 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 62135-926-01 | Clindamycin Palmitate Hydrochloride | 100 mL in 1 BOTTLE | GRANULE, FOR SOLUTION | 100 | | 1 |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 62135-926-01 | 62135092601 | 100 mL in 1 BOTTLE (62135-926-01) | 100 ml | 2025-09-10 | No | No | Historical |